Market Update (NYSE:JNJ): Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. Announce Agreement with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. to Develop and Commercialize Curative Treatments for Hepatitis B

[Business Wire] – NEW BRUNSWICK, N.J.–(BUSINESSWIRE)– Johnson & Johnson Innovation and Janssen Pharmaceuticals, Inc. today announced an exclusive license agreement with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. … Read more on this. Johnson & Johnson (JNJ) , currently valued at $276.03B, started the session at $99.13. A quick look at the market, the company’s stock traded between $98.88 and $99.83 with a trailing 52-week range being $81.79 to $106.50. JNJ shares are currently priced at 16.24x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s -3.55x earnings multiple. And for income investors, the company pays shareholders $3.00 per share annually in dividends, yielding 2.92%. According to a consensus of 19 analysts, the earnings estimate of $1.42 per share would be $0.05 better than the year-ago quarter and a $0.03 sequential decrease. In looking at the bigger picture, the full-year EPS estimate of $6.18 would be a $0.21 worse when compared to the previous year’s annual results. The quarterly earnings estimate is based on a consensus revenue forecast of the current quarter of $17.90 Billion. If realized, that would be a 1.92% decrease over the year-ago quarter. Recently, Barclays downgraded JNJ from Overweight to Equal Weight (Jan 10, 2014). Previously, RBC Capital Mkts upgraded JNJ from Sector Perform to Outperform. The average price target for JNJ shares by the analysts covering the stock is $108.00, which is 8.95% above where the stock opened this morning. See more in (NYSE:JNJ) Similar Articles: Company Update (NYSE:JNJ): Johnson & Johnson Announces Agreement To Acquire Novira Therapeutics, Inc. Stock Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Consumer Inc. Announces Completion of the Divestiture of SPLENDA® Brand to Heartland Food Products Group Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2015